2019 Update of the European AIDS Clinical Society Guidelines for Treatment of People Living With HIV Version 10.0

L Ryom; A Cotter; R De Miguel; C Béguelin; D Podlekareva; JR Arribas; C Marzolini; PGM Mallon; A Rauch; O Kirk; JM Molina; G Guaraldi; A Winston; S Bhagani; P Cinque; JD Kowalska; S Collins; M Battegay

Disclosures

HIV Medicine. 2020;21(10):617-624. 

In This Article

The Guideline Review Process

The Guidelines undergo major revisions every second year, and minor revisions in the years in between, as previously described.[2] Interim updates may be performed in the case of new key data emerging between scheduled updates. Meetings are held at regular intervals but can also be set up at short notice when necessary.

Each of the Guideline sections is created by a panel of experts governed by a three-person leadership group. The Guidelines are managed by a Guidelines Chair and Coordinator; details have previously been described.[2] As also previously reported, the recommendations provided in the EACS Guidelines are based on evidence whenever possible, and, in the rare instances where adequate evidence is unavailable, based on expert opinions.[2]

The Guidelines are extensively cross-reviewed by the panellists, and by representatives from the community and from Women Against Viruses in Europe (WAVE). Conflict of interest statements are required for all members and can be provided upon request.

In the following, the most important changes made in version 10.0 for each section of the Guidelines are described.

Comments

3090D553-9492-4563-8681-AD288FA52ACE

processing....